r-hLIF for Improving Embryo Implantation in IVF

NCT00504530 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Infertility Implantation Failure

Interventions

DRUG: Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)

Sponsor

Merck KGaA, Darmstadt, Germany